APA

Zhu M., Wang L., Yang D., Li C., Pang S., Li X., Li R., Yang B., Lian Y., Ma L., Lv Q., Jia X. & Feng L. (20200108). Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Chicago

Zhu Mao-Mao, Wang Long, Yang Dang, Li Chao, Pang Shi-Ting, Li Xing-Hua, Li Ru, Yang Bing, Lian Yuan-Pei, Ma Liang, Lv Qing-Lin, Jia Xiao-Bin and Feng Liang. 20200108. Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Harvard

Zhu M., Wang L., Yang D., Li C., Pang S., Li X., Li R., Yang B., Lian Y., Ma L., Lv Q., Jia X. and Feng L. (20200108). Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

MLA

Zhu Mao-Mao, Wang Long, Yang Dang, Li Chao, Pang Shi-Ting, Li Xing-Hua, Li Ru, Yang Bing, Lian Yuan-Pei, Ma Liang, Lv Qing-Lin, Jia Xiao-Bin and Feng Liang. Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 20200108.